Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Jul 5:5:32.
doi: 10.21037/tgh.2019.12.15. eCollection 2020.

Pancreatic cancer

Affiliations
Editorial

Pancreatic cancer

Helmut Friess et al. Transl Gastroenterol Hepatol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Figures

None
Univ.-Prof. Dr. Helmut Friess
None
Dr. Florian Scheufele

References

    1. Koch-Institut, Z.f.K.i.R. 2018. Available online: https://www.krebsdaten.de/Krebs/SiteGlobals/Forms/Datenbankabfrage/daten...
    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69:7-34. 10.3322/caac.21551 - DOI - PubMed
    1. Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, D.K., K. AWMF): S3-Leitlinie Exokrines Pankreaskarzinom, 2013 AWMF, and h.l.d.L.h. Registernummer: 032-010OL. Available online: https://www.awmf.org/leitlinien/detail/ll/032-010OL.html
    1. Hackert T, Sachsenmaier M, Hinz U, et al. Locally Advanced Pancreatic Cancer: Neoadjuvant Therapy With Folfirinox Results in Resectability in 60% of the Patients. Ann Surg 2016;264:457-63. 10.1097/SLA.0000000000001850 - DOI - PubMed
    1. Neoptolemos JP, Palmer DH, Ghaneh P, et al. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet 2017;389:1011-24. 10.1016/S0140-6736(16)32409-6 - DOI - PubMed

Publication types